Health Promotion and Disease Prevention Research Centers: 2021 Special Interest Project Competitive Supplements (SIPS)
The summary for the Health Promotion and Disease Prevention Research Centers: 2021 Special Interest Project Competitive Supplements (SIPS) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Health Promotion and Disease Prevention Research Centers: 2021 Special Interest Project Competitive Supplements (SIPS): This Notice of Funding Opportunity (NOFO) will provide supplemental funding to Prevention Research Centers (PRCs), currently funded under CDC RFA-DP-19-001; to conduct Special Interest Projects (SIPs) to design, test, evaluate, disseminate and translate effective applied public health prevention research on interventions (i.e. programs, practices, policies, or strategies) and tools developed in real-world settings to address the leading causes of illness, disabilities, and death in the United States. Research projects announced in this NOFO align with public health priorities associated with Healthy People 2030 topic areas: Adolescent Health, Arthritis, Cancer Prevention and Care, Drug and Alcohol Use, Maternal, Infant and Child Health, Mental Health and Mental Disorders, Physical Activity, and Health care access and quality.
Federal Grant Title: | Health Promotion and Disease Prevention Research Centers: 2021 Special Interest Project Competitive Supplements (SIPS) |
Federal Agency Name: | Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DP-21-004 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.135 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | March 3rd, 2021 |
Original Application Deadline: | March 3rd, 2021 |
Posted Date: | December 21st, 2020 |
Creation Date: | December 21st, 2020 |
Archive Date: | March 26th, 2021 |
Total Program Funding: | $10,080,000 |
Maximum Federal Grant Award: | $4,335,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 14 |
Cost Sharing or Matching: | No |
Last Updated: | February 18th, 2021 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education
- Additional Information on Eligibility
- Competition is limited to the 26 institutions currently funded under CDC RFA-DP-19-001.
- Grant Announcement Contact
- Natalie Darling
[email protected]
[email protected] - Similar Government Grants
- • Health Promotion and Disease Prevention Research Centers: 2024 Special Interest Project Co...
- • Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease
- • Health Promotion and Disease Prevention Research Centers: RFA-DP-24-004
- • Health Promotion and Disease Prevention Research Centers: 2023 Special Interest Project Co...
- • Health Promotion and Disease Prevention Research Centers: 2022 Special Interest Project Co...
- • Health Promotion and Disease Prevention Research Centers
- • Health Promotion and Disease Prevention Research Centers: Special Interest Project Competi...
- More Grants from the Centers for Disease Control and Prevention ERA
- • Collaborative research on influenza and other respiratory pathogens in South Africa
- • Advancing Public Health Research in Bangladesh
- • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...
- • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...
- • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...